Yes No (2) Definitely a scam
In conclusion, while the jurys still out on orforglipron, it promises to broaden access to GLP-1 therapy, making it a potentially valuable addition to our therapeutic arsenal
The FDA has not yet approved using generic tirzepatide, the active ingredient in Mounjaro
However, a recent labeling mix-up by a Texas compounding pharmacy threatened the health and safety of many and left them without the medications they need
The Journal of clinical endocrinology and metabolism , 91 (12), 47924797
Weight loss is not guaranteed and is influenced by many factors, including diet, exercise, and individual biology." The brand-reported "up to 25% body weight reduction" figure is a ceiling cited in the context of program-wide data, not a guarantee of individual outcomes